We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
-3.36%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$23.6B
AUM Growth
-$1.2B
(-4.8%)
Cap. Flow
-$152M
Cap. Flow
% of AUM
-0.64%
Top 10 Holdings %
Top 10 Hldgs %
59.63%
Holding
1,742
New
84
Increased
209
Reduced
452
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$117M |
| 2 |
Entegris
ENTG
|
+$107M |
| 3 |
Teleflex
TFX
|
+$26.6M |
| 4 |
Nike
NKE
|
+$25.8M |
| 5 |
S&P Global
SPGI
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.9M |
| 2 |
Meta Platforms (Facebook)
META
|
+$53.8M |
| 3 |
IAA
IAA, Inc. Common Stock
IAA
|
+$39.5M |
| 4 |
Amazon
AMZN
|
+$37.6M |
| 5 |
UnitedHealth
UNH
|
+$30M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.69% |
| 2 | Technology | 15.09% |
| 3 | Healthcare | 11.64% |
| 4 | Consumer Discretionary | 8.73% |
| 5 | Communication Services | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Walt Disney
DIS
$161B
| $51.2M | 0.22% |
542,651
-3,091
| -0.6% | -$331K |
|
52
US Bancorp
USB
$98.7B
| $50M | 0.21% |
1,240,325
+84,730
| +7% | +$3.92M |
|
53
Vanguard S&P 500 ETF
VOO
$967B
| $50M | 0.21% |
152,303
+1,651
| +1% | +$603K |
|
54
Domino's
DPZ
$10.7B
| $49.7M | 0.21% |
160,376
-46,114
| -22% | -$17.5M |
|
55
Pfizer
PFE
$143B
| $49.2M | 0.21% |
1,124,590
+8,583
| +0.8% | +$417K |
|
56
Capital One
COF
$123B
| $49.1M | 0.21% |
532,901
-25,042
| -4% | -$2.67M |
|
57
Canadian Natural Resources
CNQ
$98B
| $45.2M | 0.19% |
1,942,632
-25,352
| -1% | -$656K |
|
58
Eli Lilly
LLY
$1.06T
| $39.2M | 0.17% |
121,148
-10,502
| -8% | -$3.33M |
|
59
United Therapeutics
UTHR
$26.4B
| $38.4M | 0.16% |
183,400
+57,200
| +45% | +$12.8M |
|
60
Cencora
COR
$59.4B
| $38M | 0.16% |
280,746
-8,927
| -3% | -$1.28M |
|
61
Immunocore
IMCR
$1.81B
| $37.4M | 0.16% |
795,849
| – | – |
|
62
IQVIA
IQV
$34.6B
| $36.6M | 0.15% |
201,821
-8,264
| -4% | -$1.81M |
|
63
Arrowhead Research
ARWR
$12.2B
| $36.5M | 0.15% |
1,105,587
-1,075
| -0.1% | -$43.4K |
|
64
Stryker
SYK
$122B
| $35.7M | 0.15% |
176,416
-5,672
| -3% | -$1.19M |
|
65
Moody's
MCO
$82.5B
| $35.3M | 0.15% |
145,238
-11,464
| -7% | -$3.33M |
|
66
Procter & Gamble
PG
$342B
| $34.9M | 0.15% |
280,766
-5,548
| -2% | -$788K |
|
|
HOLX
67
DELISTED
Hologic
HOLX
| $33.3M | 0.14% |
516,700
| – | – |
|
68
Evolus
EOLS
$394M
| $32.5M | 0.14% |
4,034,938
| – | – |
|
|
SCHW
69
Charles Schwab
SCHW
$177B
| $31.9M | 0.14% |
444,317
-97
| -0% | -$6.73K |
|
70
Amgen
AMGN
$201B
| $31.9M | 0.14% |
144,260
-6,962
| -5% | -$1.69M |
|
71
Starbucks
SBUX
$118B
| $31.9M | 0.14% |
412,411
-17,800
| -4% | -$1.51M |
|
72
Ingredion
INGR
$6.32B
| $30.2M | 0.13% |
374,656
-16,620
| -4% | -$1.46M |
|
73
JPMorgan Chase
JPM
$930B
| $29.2M | 0.12% |
280,604
-955
| -0.3% | -$110K |
|
74
AB InBev
BUD
$155B
| $28.7M | 0.12% |
635,612
-18,920
| -3% | -$980K |
|
75
United Parcel Service
UPS
$97B
| $27.7M | 0.12% |
171,371
-1,517
| -0.9% | -$287K |
|
Similar funds
SAM
First Manhattan's Q3 2022 Portfolio in Review
As of Q3 2022, First Manhattan held 1,742 positions worth $23.6B, down 4.8% from $24.8B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
First Manhattan's Q3 2022 filing shows 84 new, 209 increased, 452 reduced and 104 closed positions. Its largest new stake was Element Solutions: 151,800 shares worth $2.47M. The largest sale was Apple, an estimated $59.9M.
By sector, the portfolio is most concentrated in Financials at 44% of assets, up from 43% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2022 buy was Element Solutions: 151,800 shares worth $2.47M.
- First Manhattan added most to Linde in Q3 2022, an estimated $117M increase.
- First Manhattan's biggest Q3 2022 reduction was Apple, cutting an estimated $59.9M.
- First Manhattan fully exited Blueprint Medicines in Q3 2022, selling an estimated $29.7M.
- First Manhattan's ten largest holdings make up 60% of its $23.6B portfolio in Q3 2022.
- First Manhattan opened 84 new positions and closed 104 in Q3 2022.
- First Manhattan's portfolio value fell 4.8% quarter-over-quarter to $23.6B.
Based on First Manhattan's 13F filing for Q3 2022, filed 14 Nov 2022.